Skip to main content
. 2017 Oct 20;14(6):8190–8196. doi: 10.3892/ol.2017.7233

Figure 3.

Figure 3.

Kaplan-Meier analysis of recurrence-free survival according to ARHGDIB expression in clear cell renal cell carcinoma tissue. Higher ARHGDIB expression was associated with a longer RFS (hazard ratio, 0.11; 95% confidence interval, 0.03–0.46; P=0.0024) on univariate Cox regression analysis. ARHGDIB, Rho GDP dissociation inhibitor-β.